Crohn’s Disease and Ulcerative Colitis | TreatmentTrends | EU | 2015

The TreatmentTrends Crohn’s Disease and Ulcerative Colitis (EU) report explores current trends in the management of CD and UC from the perspective of 250 treating EU5 gastroenterologists. The report covers use and patient share of key CD/UC therapies (both biologics and nonbiologics), perceived strengths and weaknesses of the main brands, barriers to broader uptake, brand representative performance, the product attributes that are most important to gastroenterologists, and anticipated uptake of biosimilars and other emerging therapies for these indications.

Back to all Market Assessment reports

Contact us

Investors

Careers

Login

Crohn’s Disease and Ulcerative Colitis | TreatmentTrends | EU | 2015

Related Market Assessment Reports

Ulcerative Colitis – Current Treatment – Detailed, Expanded Analysis: Pediatric (US)

Ulcerative Colitis – Landscape & Forecast – Disease Landscape & Forecast

Crohn’s Disease – Access & Reimbursement – Detailed, Expanded Analysis: Ulcerative Colitis And Crohn’s Disease (US)

Ulcerative Colitis – Access & Reimbursement – Detailed, Expanded Analysis: Ulcerative Colitis And Crohn’s Disease (US)

Ulcerative Colitis – Unmet Need – Detailed, Expanded Analysis: Moderate To Severe Ulcerative Colitis (US/EU)